Giovanna Liuzzo

Author PubWeight™ 53.43‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Widespread coronary inflammation in unstable angina. N Engl J Med 2002 3.60
2 Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function. Eur Heart J 2005 2.33
3 Widespread myocardial inflammation and infarct-related artery patency. Circulation 2004 2.27
4 High telomerase activity in neutrophils from unstable coronary plaques. J Am Coll Cardiol 2007 1.61
5 Delayed neutrophil apoptosis in patients with unstable angina: relation to C-reactive protein and recurrence of instability. Eur Heart J 2009 1.46
6 Endothelial and smooth muscle cells dysfunction distal to recanalized chronic total coronary occlusions and the relationship with the collateral connection grade. JACC Cardiovasc Interv 2012 1.41
7 [Inflammation in acute coronary syndromes: mechanisms and clinical implications]. Rev Esp Cardiol 2004 1.40
8 Instability mechanisms in unstable angina according to baseline serum levels of C-reactive protein: the role of thrombosis, fibrinolysis and atherosclerotic burden. Int J Cardiol 2007 1.39
9 Inflammation as a possible link between coronary and carotid plaque instability. Circulation 2004 1.23
10 Atherothrombosis, inflammation, and diabetes. J Am Coll Cardiol 2003 1.20
11 Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus. Eur Heart J 2011 1.17
12 Antibody response to chlamydial heat shock protein 60 is strongly associated with acute coronary syndromes. Circulation 2003 1.14
13 Paradoxical preservation of vascular function in severe obesity. Am J Med 2010 1.08
14 Gene expression profiles in peripheral blood mononuclear cells of chronic heart failure patients. Physiol Genomics 2009 1.07
15 Identification of protein disulfide isomerase as a cardiomyocyte survival factor in ischemic cardiomyopathy. J Am Coll Cardiol 2007 1.07
16 Risk of myocardial infarction and angina in patients with severe peripheral vascular disease: predictive role of C-reactive protein. Circulation 2002 1.04
17 Pathogenesis of acute coronary syndromes. J Am Coll Cardiol 2012 1.00
18 Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial. Int J Cardiol 2008 0.97
19 Infarct-related artery occlusion, tissue markers of ischaemia, and increased apoptosis in the peri-infarct viable myocardium. Eur Heart J 2005 0.97
20 COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment. Eur Heart J 2009 0.97
21 Laminar shear stress inhibits CXCR4 expression on endothelial cells: functional consequences for atherogenesis. FASEB J 2005 0.96
22 Modulation of CD4(+)CD28null T lymphocytes by tumor necrosis factor-alpha blockade in patients with unstable angina. Circulation 2006 0.93
23 Adaptive immunity, inflammation, and cardiovascular complications in type 1 and type 2 diabetes mellitus. J Diabetes Res 2013 0.92
24 Intracoronary microparticles and microvascular obstruction in patients with ST elevation myocardial infarction undergoing primary percutaneous intervention. Eur Heart J 2012 0.92
25 Increase of plasma IL-9 and decrease of plasma IL-5, IL-7, and IFN-γ in patients with chronic heart failure. J Transl Med 2011 0.90
26 Independent prognostic value of C-reactive protein and coronary artery disease extent in patients affected by unstable angina. Atherosclerosis 2007 0.89
27 Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the rigenera study). Am J Cardiol 2007 0.88
28 Interleukin-17 in atherosclerosis and cardiovascular disease: the good, the bad, and the unknown. Eur Heart J 2012 0.86
29 Infections, immunity and atherosclerosis: pathogenic mechanisms and unsolved questions. Int J Cardiol 2012 0.85
30 C-reactive protein and other inflammatory biomarkers as predictors of outcome following acute coronary syndromes. Semin Vasc Med 2003 0.84
31 Ischemia and apoptosis in an animal model of permanent infarct-related artery occlusion. Int J Cardiol 2006 0.82
32 Different apparent prognostic value of hsCRP in type 2 diabetic and nondiabetic patients with acute coronary syndromes. Clin Chem 2009 0.82
33 Pioglitazone reduces monocyte activation in type 2 diabetes. Acta Diabetol 2008 0.81
34 Role of tissue C-reactive protein in atrial cardiomyocytes of patients undergoing catheter ablation of atrial fibrillation: pathogenetic implications. Europace 2011 0.81
35 Association between C-reactive protein and angiographic restenosis after bare metal stents: an updated and comprehensive meta-analysis of 2747 patients. Cardiovasc Revasc Med 2008 0.81
36 Thromboxane production in morbidly obese subjects. Am J Cardiol 2011 0.81
37 CD4+CD28 null T lymphocytes are expanded in young women with polycystic ovary syndrome. Fertil Steril 2011 0.80
38 Acute coronary syndromes: to CRP or not to CRP? J Am Coll Cardiol 2008 0.79
39 Endothelial progenitor cells in morbid obesity. Circ J 2014 0.79
40 Combined role of the Lewis antigenic system, Chlamydia pneumoniae, and C-reactive protein in unstable angina. J Am Coll Cardiol 2003 0.78
41 Altered CD31 expression and activity in helper T cells of acute coronary syndrome patients. Basic Res Cardiol 2014 0.78
42 1059G/C polymorphism within the exon 2 of the C-reactive protein gene: relationship to C-reactive protein levels and prognosis in unstable angina. Coron Artery Dis 2007 0.77
43 Immunomodulator activity of 3-hydroxy-3-methilglutaryl-CoA inhibitors. Cardiovasc Hematol Agents Med Chem 2009 0.77
44 Reversible atrial gap junction remodeling during hypoxia/reoxygenation and ischemia: a possible arrhythmogenic substrate for atrial fibrillation. Gen Physiol Biophys 2012 0.77
45 CD4(+)CD28(null) T lymphocyte frequency, a new marker of cardiovascular risk: relationship with polycystic ovary syndrome phenotypes. Fertil Steril 2012 0.77
46 Role of the CD14 C(-260)T promoter polymorphism in determining the first clinical manifestation of coronary artery disease. J Cardiovasc Med (Hagerstown) 2010 0.77
47 Cardiovascular risk in obesity: different activation of inflammation and immune system between obese and morbidly obese subjects. Eur J Intern Med 2011 0.76
48 Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial. Reprod Sci 2013 0.76
49 Effects of bariatric surgery on cardiac remodeling: clinical and pathophysiologic implications. Int J Cardiol 2013 0.75
50 Parvovirus B19 at the culprit coronary stenosis predicts outcome after stenting. Eur J Clin Invest 2013 0.75
51 The cardiovascular relevance of celiac disease. Diabetes Care 2012 0.75
52 Chlamydia pneumoniae in coronary atherosclerotic plaques and coronary instability. Int J Cardiol 2011 0.75
53 The complex link between oxidised low-density lipoprotein and unstable angina. J Cardiovasc Med (Hagerstown) 2007 0.75
54 [Genetic modulation in the inflammatory process of ischemic cardiopathy]. Ital Heart J Suppl 2002 0.75